mRNA vaccination facilitates the prevention and control of infectious diseases at an unprecedented speed

#mRNAvaccines, propelled by #COVID19, enable rapid development, adaptability, strong immune responses, and potential for #PersonalizedMedicine, yet face scientific and regulatory hurdles, highlighting promise in future #VaccineInnovation.

#OpenAccess: doi.org/10.1016/j.dc...

Rotavirus Could Come Roaring Back—Very Soon A leading vaccine expert on what the country’s newly overhauled immunization schedule means for children

gift link #VaccineInnovation #DecentralizedHealth #ImmunizationRevolution #CommunityWellness #FutureOfSocialSharing

www.theatlantic.com/health/2026/...

Experimental vaccine prevents dangerous allergic attack for a year By blocking a molecule that pushes the immune system into overdrive, a vaccine protects mice from life-threatening anaphylaxis

Experimental vaccine prevents dangerous allergic attack for a year #Science #HealthandMedicine #Allergies #AllergyResearch #VaccineInnovation #PublicHealth

Particles that enhance mRNA delivery could reduce vaccine dosage and costs

Exciting news for global health! 🔬 Particles designed to supercharge mRNA delivery could lead to more efficient vaccines, potentially requiring smaller doses and making them more affordable worldwide. #VaccineInnovation #PublicHealth

First Elephant Herpesvirus Vaccine Could Save Endangered Species All the science news you can handle in a single feed

First Elephant Herpesvirus Vaccine Could Save Endangered Species #Science #HealthandMedicine #InfectiousDiseases #ElephantConservation #WildlifeHealth #VaccineInnovation

Oxford’s CoI‑AI project: predicting immunity to beat bacteria - Advanced Oxford Oxford’s CoI-AI programme uses AI, human challenge models and immunology to accelerate vaccine design against resistant bacterial threats.

Oxford's CoI-AI programme unites our members, the University of Oxford and the Ellison Institute of Technology, to advance vaccine design and fight antibiotic resistance.

🔗 www.advancedoxford.com/oxfords-col%...

#VaccineInnovation #AntibioticResistance #OxfordScience

Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines | Annual Reviews T cells are key effectors of anticancer immunity. They are capable of distinguishing tumor cells from normal ones by recognizing major histocompatibility complex–bound cancer-specific peptides. Accumu...

What if every cancer vaccine was made just for you?

This article explores how tumor-specific mutations are being used to create fully personalized cancer immunotherapies.

🔗 Read without restriction: arevie.ws/Vac_TIC

#CancerResearch #VaccineInnovation #OpenAccess

A vaccine with no needles? This platform might make it possible.

This review explores how bacteriophage T4 could deliver needle-free, mucosal vaccines for future pandemics.

🔗 Freely available to read: arevie.ws/Vac_BNF

#VaccineInnovation #OpenAccess

US Needle Free Injection System Market Growth Insights 2035 US Needle Free Injection System Market to Grow at a CAGR of 9.326% (2025 - 2035), US Needle Free Injection System Market Industry Analysis by Application, Technology, End Use, Distribution Channel

💉 Without the poke! The US leads in #NeedleFreeInjection tech for pain-free drug delivery & mass immunization.
#SmartHealthcare #NoNeedleRevolution #VaccineInnovation #PainFreeShots

www.marketresearchfuture.com/reports/us-n...

COVID-19 Vaccine's mRNA Technology Adapted for First Antibiotic-Resistant Bacteria Vaccine Researchers have created the world's first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium — and they did it using the platform developed for COVID-19 vaccines. Medical Express publishes...

COVID-19 Vaccine's mRNA Technology Adapted for First Antibiotic-Resistant Bacteria Vaccine #Technology #EmergingTechnologies #Biotechnology #mRNAtechnology #antibioticresistance #vaccineinnovation

🦟 Cracking the malaria code! Iranian mosquito study reveals 16 immunogenic epitopes in FREP1 protein - a potential game-changer for transmission-blocking vaccines 🧬💉 #Genomics #MalariaResearch #VaccineInnovation https://emmecola.github.io/genomics-daily

This article explores mRNA vaccines, their role, limitations, and advancements. Their rapid production time and adaptability make them a critical tool in the fight against both current and emerging infectious threats.

hubs.ly/Q03rfxkX0

#VaccineInnovation #mRNAVaccines

🦋 Silkworms for vaccines?

French biotech NEVEZYNE is developing a low-cost, scalable platform—starting with Ebola GP antigen.

With ISIDORe & EATRIS support, they refined their regulatory strategy & TPP to prep for clinical steps.

#ISIDORe #VaccineInnovation #Biomanufacturing #Ebola

Dr Ricardo Rosales is exploring how vaccinia viruses, once vital in eradicating smallpox, are now paving the way for new vaccines and cancer treatments. Find out more: scitube.io/dr-ricardo-r... #VaccineInnovation #CancerResearch

From COVID to cancer: Why Canada’s RNA vaccine leadership matters more than ever
#Canada #Vaccines #RNAVaccines #mRNA #Health #RNA #VaccineInnovation #CancerResearch #PublicHealth #HealthEquity #Biotech #COVID19 #ImmunizationWeek #VaccineLeadership
the-14.com/from-covid-t...

‘Revolutionary’ fridge-free vaccines to be trialled in UK

Game-changing fridge-free vaccines are coming to the UK! 💉 This could revolutionize global health access. #vaccineinnovation #globalhealth #fridgefreevaccine

The fight against infectious diseases is a global effort. On this #WorldImmunizationWeek, we highlight the essential role of research and collaboration in developing safe, effective vaccines that protect us all. #ResearchForHealth #VaccineInnovation

The Immune System’s Hidden Power Move: A Second Phase of T-Cell Activation New research reveals that T-cells don’t just activate once—they undergo a two-phase process that supercharges the immune response. This discovery could change everything from vaccines to cancer therapies.

What if your immune system had a second, secret step that made it smarter and stronger? It does—and scientists just found it. #ImmuneBreakthrough #VaccineInnovation #Tcells

MOPEVACLAS vaccine candidate for Lassa fever enters clinical trials After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut Past...

🔬 After 20+ years of research, Institut Pasteur scientists have developed MOPEVAC, a groundbreaking vaccine platform. First target 💉 Lassa fever, a disease that kills thousands annually. #VaccineInnovation #PublicHealth #LassaVirus

US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine.

🚨 Big win in global health! The FDA approves a freeze-dried version of the Jynneos mpox & smallpox vaccine by Bavarian Nordic, enhancing storage & transportation for long-term stockpiling. 💉🌍 #PublicHealth #VaccineInnovation #Mpox #Smallpox
www.reuters.com/sustainabili...

Would you prefer a needle-free vaccine?

Oxford researchers have created the OBSRVT tool to evaluate public attitudes toward nasal sprays & microneedle patches, aiming to improve vaccine accessibility & reduce hesitancy.

🔗https://tinyurl.com/VaccineDelivery

#VaccineInnovation

Universo flu vaccine development breakthrough! Australian scientists celebrate major progress. #VaccineInnovation https://fefd.link/ZN495

Cracking viral vaccine code! 🦠💉 Computational magic turns Zika virus into a potential lifesaver - 80% survival in mice! Groundbreaking vaccine design that could reshape immunology. 🧬 #VaccineInnovation #GenomicBreakthrough https://emmecola.github.io/genomics-daily

Needle-Free Vaccines: Stanford Researchers Develop Topical Vaccine Cream Using Skin Bacteria - SynBioBeta

The study reveals how antibodies produced in response to skin bacteria could lead to a new type of living vaccine applied directly to the skin
#NeedleFreeVaccines #VaccineInnovation #StanfordResearch #SkinBacteria

Strong Initial Antigen Stimulation Could Pave the Way for Lasting HIV Immunity Without Continuous Vaccination | Science Featured Series Researchers have recently published a study in Vaccines that examines how the HIV treatment and immune profile affect the body’s ability to fight off the vi ...

Dr. Victor Sanchez-Merino and Dr. Eloisa Yuste of the Carlos III Health Institute published in Vaccines that strong initial antigen exposure may help create lasting HIV immunity, advancing vaccine strategies.
scft.link/1KYED

#HIVresearch #vaccineinnovation #immunology #globalhealth